GARCHING & MUNICH, Germany–(BUSINESS WIRE)–ITM AG, a leading radiopharmaceutical biotech company, today announced that it has signed a strategic long-term agreement to create a Joint Venture with Chengdu Gaotong Isotope Co. Ltd., the leading provider…

Click here to view the original article.